SIEMENS HEALTH ADR/050 Market Cap ($46.68 Billion)
Market Cap & Net Worth: SIEMENS HEALTH ADR/050 (SHL1)
SIEMENS HEALTH ADR/050 market cap. SIEMENS HEALTH ADR/050 (F:SHL1) has a market capitalization of $46.68 Billion (€39.93 Billion) as of November 1, 2026. Listed on the F stock exchange, this Germany-based company holds position #573 globally and #117 in its home market, demonstrating a -9.64% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SIEMENS HEALTH ADR/050's stock price €17.80 by its total outstanding shares 2243111308 (2.24 Billion). Also see SIEMENS HEALTH ADR/050 (SHL1) cash flow conversion for how efficiently the company converts equity into cash flow.
SIEMENS HEALTH ADR/050 Market Cap History (2018–2026)
SIEMENS HEALTH ADR/050 market cap history from 2018 to 2026. Data shows growth from $41.12 Billion to $55.07 Billion (0.71% CAGR). Check current stock price of SIEMENS HEALTH ADR/050 for real-time trading data and today's change.
SIEMENS HEALTH ADR/050 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SIEMENS HEALTH ADR/050's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore SIEMENS HEALTH ADR/050 (SHL1) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2.96x
SIEMENS HEALTH ADR/050's market cap is 2.96 times its annual revenue
Latest Price to Earnings (P/E) Ratio
34.03x
SIEMENS HEALTH ADR/050's market cap is 34.03 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $59.93 Billion | $21.71 Billion | $2.04 Billion | 2.76x | 29.41x |
| 2023 | $67.33 Billion | $21.68 Billion | $1.51 Billion | 3.11x | 44.62x |
| 2024 | $66.09 Billion | $22.36 Billion | $1.94 Billion | 2.96x | 34.03x |
Competitor Companies of SHL1 by Market Capitalization
Companies near SIEMENS HEALTH ADR/050 in the global market cap rankings as of November 1, 2026. Also see SIEMENS HEALTH ADR/050 assets under control for a full breakdown of the balance sheet.
Key companies related to SIEMENS HEALTH ADR/050 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $184.67 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #215 globally with a market cap of $111.95 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $184.67 Billion | $106.20 |
| #215 | Stryker Corporation | NYSE:SYK | $111.95 Billion | $291.86 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $96.54 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of SIEMENS HEALTH ADR/050 (2018–2026)
Market capitalization of SIEMENS HEALTH ADR/050 from 2018 to today. Between 2018 and today, SIEMENS HEALTH ADR/050's market cap moved from $41.12 Billion to $ 55.07 Billion, with a yearly change of 0.71%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €55.07 Billion | -3.67% |
| 2025 | €57.17 Billion | -13.49% |
| 2024 | €66.09 Billion | -1.85% |
| 2023 | €67.33 Billion | +12.34% |
| 2022 | €59.93 Billion | -24.75% |
| 2021 | €79.65 Billion | +61.00% |
| 2020 | €49.47 Billion | -1.71% |
| 2019 | €50.34 Billion | +22.40% |
| 2018 | €41.12 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of SIEMENS HEALTH ADR/050 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $46.68 Billion USD |
| MoneyControl | $46.68 Billion USD |
| MarketWatch | $46.68 Billion USD |
| marketcap.company | $46.68 Billion USD |
| Reuters | $46.68 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SIEMENS HEALTH ADR/050
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound sys… Read more